Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 208

1.

In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition.

Hoxha M, Buccellati C, Capra V, Garella D, Cena C, Rolando B, Fruttero R, Carnevali S, Sala A, Rovati GE, Bertinaria M.

Pharmacol Res. 2016 Jan;103:132-43. doi: 10.1016/j.phrs.2015.11.012. Epub 2015 Nov 24.

PMID:
26621246
2.

Inhibition of Brain Mitogen-Activated Protein Kinase Signaling Reduces Central Endoplasmic Reticulum Stress and Inflammation and Sympathetic Nerve Activity in Heart Failure Rats.

Wei SG, Yu Y, Weiss RM, Felder RB.

Hypertension. 2016 Jan;67(1):229-36. doi: 10.1161/HYPERTENSIONAHA.115.06329. Epub 2015 Nov 16.

PMID:
26573710
3.

Acute restraint stress increases carotid reactivity in type-I diabetic rats by enhancing Nox4/NADPH oxidase functionality.

Moreira JD, Pernomian L, Gomes MS, Pernomian L, Moreira RP, do Prado AF, da Silva CH, de Oliveira AM.

Eur J Pharmacol. 2015 Oct 15;765:503-16. doi: 10.1016/j.ejphar.2015.09.020. Epub 2015 Sep 24.

PMID:
26387612
4.

IL-1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase-2 and prostaglandin E2.

Al-Kofahi M, Becker F, Gavins FN, Woolard MD, Tsunoda I, Wang Y, Ostanin D, Zawieja DC, Muthuchamy M, von der Weid PY, Alexander JS.

Br J Pharmacol. 2015 Aug;172(16):4038-51. doi: 10.1111/bph.13194. Epub 2015 Jul 6.

PMID:
25989136
5.

IKK inhibition prevents PM2.5-exacerbated cardiac injury in mice with type 2 diabetes.

Zhao J, Liu C, Bai Y, Wang TY, Kan H, Sun Q.

J Environ Sci (China). 2015 May 1;31:98-103. doi: 10.1016/j.jes.2014.10.018. Epub 2015 Mar 25.

PMID:
25968264
6.

Omega-3 polyunsaturated fatty acids as an angelus custos to rescue patients from NSAID-induced gastroduodenal damage.

Park JM, Han YM, Jeong M, Kim EH, Ko WJ, Cho JY, Hahm KB.

J Gastroenterol. 2015 Jun;50(6):614-25. doi: 10.1007/s00535-014-1034-z. Epub 2015 Jan 13. Review.

PMID:
25578017
7.
8.
9.

[Diclofenac: update on tolerableness and spinal anti-inflammatory action].

Sandri A.

Minerva Med. 2014 Aug;105(4):313-8. Italian.

PMID:
25078485
10.

Cardiovascular risk associated with celecoxib or etoricoxib: a meta-analysis of randomized controlled trials which adopted comparison with placebo or naproxen.

De Vecchis R, Baldi C, Di Biase G, Ariano C, Cioppa C, Giasi A, Valente L, Cantatrione S.

Minerva Cardioangiol. 2014 Dec;62(6):437-48. Epub 2014 Jul 16.

PMID:
25029569
11.

[Meloxicam: the golden mean of nonsteroidal anti-inflammatory drugs].

Karateev AE.

Ter Arkh. 2014;86(5):99-105. Review. Russian.

PMID:
25026810
12.

A cost-effectiveness analysis of celecoxib compared with diclofenac in the treatment of pain in osteoarthritis (OA) within the Swedish health system using an adaptation of the NICE OA model.

Brereton N, Pennington B, Ekelund M, Akehurst R.

J Med Econ. 2014 Sep;17(9):677-84. doi: 10.3111/13696998.2014.933111. Epub 2014 Jun 30.

PMID:
24914585
13.

PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes.

Chien PT, Hsieh HL, Chi PL, Yang CM.

Br J Pharmacol. 2014 Oct;171(19):4504-19. doi: 10.1111/bph.12794. Epub 2014 Sep 5.

14.

COX-2 protects against atherosclerosis independently of local vascular prostacyclin: identification of COX-2 associated pathways implicate Rgl1 and lymphocyte networks.

Kirkby NS, Lundberg MH, Wright WR, Warner TD, Paul-Clark MJ, Mitchell JA.

PLoS One. 2014 Jun 2;9(6):e98165. doi: 10.1371/journal.pone.0098165. eCollection 2014.

15.

Involvement of COX2-thromboxane pathway in TCDD-induced precardiac edema in developing zebrafish.

Teraoka H, Okuno Y, Nijoukubo D, Yamakoshi A, Peterson RE, Stegeman JJ, Kitazawa T, Hiraga T, Kubota A.

Aquat Toxicol. 2014 Sep;154:19-26. doi: 10.1016/j.aquatox.2014.04.025. Epub 2014 May 2.

16.

Nonsteroidal anti-inflammatory drugs and the heart.

Patrono C, Baigent C.

Circulation. 2014 Feb 25;129(8):907-16. doi: 10.1161/CIRCULATIONAHA.113.004480. Review. No abstract available.

17.

Cardiovascular risks of cyclooxygenase-2 inhibitors and traditional anti-inflammatory drugs: necessary but not sufficient for clinical decision making.

Hennekens CH, Borzak S, Bjorkman DJ.

Expert Rev Cardiovasc Ther. 2014 Mar;12(3):291-3. doi: 10.1586/14779072.2014.873700. Epub 2014 Feb 6.

PMID:
24502626
18.

Investigation of the functional expression of purine and pyrimidine receptors in porcine isolated pancreatic arteries.

Alsaqati M, Chan SL, Ralevic V.

Purinergic Signal. 2014;10(2):241-9. doi: 10.1007/s11302-013-9403-2. Epub 2013 Dec 6.

19.

Variability in the response to non-steroidal anti-inflammatory drugs: mechanisms and perspectives.

Bruno A, Tacconelli S, Patrignani P.

Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):56-63. doi: 10.1111/bcpt.12117. Epub 2013 Sep 3. Review.

20.

Coreosides A-D, C14-polyacetylene glycosides from the capitula of Coreopsis tinctoria and its anti-inflammatory activity against COX-2.

Zhang Y, Shi S, Zhao M, Chai X, Tu P.

Fitoterapia. 2013 Jun;87:93-7. doi: 10.1016/j.fitote.2013.03.024. Epub 2013 Apr 2.

PMID:
23562631
Items per page

Supplemental Content

Loading ...
Write to the Help Desk